Scholars Central

Conference abstractPublished 2021

LCMS application for investigating stability of extemporaneously compounded preparations and studying pharmacokinetics in clinical trials

Authors: Gagan Kaushal, Ankit K. Rochani

Thomas Jefferson University, Philadelphia

Abstract

Pharmaceutical compounding of formulation as per United States Pharmacopeia (USP) has been a major scientific challenge for hospital pharmacies across the United States. The main advantage of compounding is to have economical and customized delivery of drugs as per the patient needs in a hospital setting. Most sterile and non-sterile formulations compounded in any clinical setting are assigned with the beyond-use date (BUD) as per the standards given by USP. Limited information exists towards the investigation on the extended BUDs or degradation of the compounded formulations. Many studies have shown that the compounded preparation's active pharmaceutical ingredients (API) can have extended stabilities if stored under specific conditions. This can significantly extend the BUDs (beyond the standard recommendations) of the compounded preparations in the hospital. With the development of high resolution and sensitive liquid chromatography and mass spectrometry, it is possible to investigate extended BUDs of various formulations that hospital pharmacies develop under different temperatures, humidity, and other stress conditions. HPLC or LCMS studies have helped us to study and provide recommendations for extended stability of compounded preparations at Thomas Jefferson University Hospital Pharmacy. Our laboratory has developed highly sensitive analytical (HPLC/ LCMS) assays to study the stability of 5-FU, vancomycin, buprenorphine, lonidamine, and other preperations in their respective formulations. The assays had sensitivities in nanogram/mL concentrations with %CV and %recoveries as <5% and 100±10%, respectively. We have used these LCMS assays for determining the BUD for the compounded preparations, based on the degradation profile over time under specific storage conditions. Being an LCMS-based bioanalytical lab, we also support trials of active drug molecules in clinical and preclinical setups with our highly sensitive quantitation assays. In the present talk, we would like to share the LCMS method development stories and highlight the significance of therapeutic drug monitoring by connecting analytical laboratories to compounding pharmacies and hospitals for developing personalized therapeutic solutions.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Food and Nutritional Disorders
  • SubjectNutrition & Food Science
  • BylineArticles whose byline prints “Gagan Kaushal”
  • BylineArticles whose byline prints “Ankit K. Rochani”